Lumexa Imaging (NASDAQ:LMRI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Lumexa Imaging (NASDAQ:LMRI) from a hold rating to a buy rating in a report released on Sunday morning.

Several other equities analysts also recently commented on LMRI. Weiss Ratings raised shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research note on Thursday, June 25th. Deutsche Bank Aktiengesellschaft set a $16.00 price target on Lumexa Imaging in a report on Thursday, August 13th. Finally, Barclays lowered their price target on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $16.00.

Lumexa Imaging Stock Up 1.5%

Shares of NASDAQ LMRI opened at $11.99 on Friday. The firm’s fifty day moving average is $10.99 and its 200 day moving average is $10.86. Lumexa Imaging has a 52 week low of $6.45 and a 52 week high of $19.45. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 1.40. The company has a market cap of $1.15 billion and a price-to-earnings ratio of -24.47.

Lumexa Imaging (NASDAQ:LMRI) last announced its quarterly earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.17. The firm had revenue of $264.16 million for the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. On average, equities research analysts expect that Lumexa Imaging will post 0.27 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC bought a new position in Lumexa Imaging in the first quarter worth about $778,000. Janus Henderson Group PLC boosted its position in Lumexa Imaging by 5.4% during the 1st quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock valued at $18,063,000 after acquiring an additional 107,903 shares in the last quarter. Monashee Investment Management LLC bought a new stake in Lumexa Imaging during the 4th quarter valued at approximately $2,775,000. Seven Grand Managers LLC purchased a new position in shares of Lumexa Imaging during the 4th quarter worth approximately $11,942,000. Finally, Element Capital Management LLC purchased a new position in shares of Lumexa Imaging during the 4th quarter worth approximately $1,616,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).